low glutathione and kidney disease Emerging Role of Ferroptosis in Diabetic Disease: Molecular Mechanisms Therapeutic Opportunities Do You Have a Glutathione

BPC-157 has demonstrated cytoprotective and wound-healing properties across gastrointestinal, musculoskeletal, and neurological models, acting through VEGF-mediated angiogenesis and nitric oxide system modulation

Consequently, iron metabolism constitutes a promising and largely unexploited therapeutic target for the development of new pharmacological treatments for these diseases

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Viana M.L., Santos R.G., Generoso S.V., Arantes R.M., Correia M.I., Cardoso V.N